Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Current opinions on Noonan syndrome and RASopathies
Kathryn Nicole Weaver1,2,3, Carlos E Prada4,5
1The Heart Institute, Cincinnati Children's Hospital Medical Center.
Insights
Noonan syndrome and related disorders (RASopathies) impact many children. Recent advances include targeted therapies like trametinib for severe symptoms and better understanding of genotype-phenotype correlations and neurologic issues.
Area of Science:
- Genetics
- Pediatric Medicine
- Pharmacology
Background:
- Noonan syndrome and related disorders (RASopathies) are genetic conditions affecting approximately 1 in 2000 individuals.
- These disorders present with diverse phenotypic manifestations, requiring recognition by pediatric providers.
- Understanding RASopathies is crucial for timely diagnosis and management.
Purpose of the Study:
- To review recent advancements in the diagnosis and treatment of RASopathies.
- To inform pediatricians and subspecialists about common diagnostic features and emerging therapies.
- To highlight the importance of recognizing RASopathy diagnoses in clinical practice.
Main Methods:
- Review of major research articles published on RASopathies in the past 18 months.
- Analysis of studies focusing on pathway-targeted drugs, genotype-phenotype correlations, and neurologic manifestations.
- Synthesis of findings related to diagnosis, natural history, and treatment endpoints.
Main Results:
- Pathway-targeted drugs, such as trametinib, show promise for refractory cardiac and lymphatic manifestations.
- Emerging genotype-phenotype correlations are refining the understanding of these disorders.
- Detailed characterization of neurologic manifestations is a significant area of recent research.
Conclusions:
- Pathway-targeted therapy, exemplified by trametinib use, underscores the need for accurate RASopathy diagnosis.
- Further refinement of genotype-phenotype correlations is essential for personalized treatment.
- Continued research into the phenotypic spectrum, especially neurologic aspects, will drive future knowledge growth.
Purpose Of Review:
Noonan syndrome and related disorders (RASopathies) affect ~1 in 2000 individuals and are associated with a wide range of phenotypic manifestations. It is highly likely that pediatricians and other pediatric subspecialists will encounter multiple patients with these diagnoses in their clinical practice. It is important that pediatric providers recognize common diagnostic features and are informed regarding recent advances in diagnosis and emerging treatment options for patients with these conditions.
Recent Findings:
Major themes of research articles published about RASopathies in the past 18 months include the utilization of pathway targeted drugs such as trametinib for treatment-refractory cardiac and lymphatic manifestations, emerging genotype-phenotype correlations, and detailed characterization of neurologic manifestations.
Summary:
The potential for pathway targeted therapy, with increasing reported use of trametinib for severe cardiac and lymphatic manifestations of RASopathies, exemplifies the importance of recognizing RASopathy diagnoses and of clearly defining natural history and treatment endpoints. Further refinement of genotype-phenotype correlations and the phenotypic spectrum, particularly the delineation of neurologic manifestations clinically and radiographically, are likely to be areas of significant knowledge growth in upcoming years.
More Related Videos
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
Incomplete Dominance
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pleiotropy
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...